George Clinical renal research experts and scientific leaders will be on hand for the 5th Chronic Kidney Disease Drug Development Summit in Boston March 7–9. Contact Matthew Reabold or your business development lead to book a meeting.
After multiple years as a virtual-only event, CKD promises to put a spotlight on untapped pathways for therapeutic intervention, establishing a well-defined pathway in rare disease, and constructing robust clinical programs to shorten clinical trials.
George Clinical Chief Medical Officer Maria Ali, scientific leader’s Hiddo Heerspink and Roberto Pecoits-Filho and Vice President, Head of Clinical Renal AstraZeneca, Jerome Rossert will lead a high-profile panel discussion during the summit entitled Global Kidney Patients Trial Network (GKPTN): A paradigm shift in the conduct of renal studies. Keeping with the mission of CKD this year, the panel will address: how the industry can more efficiently execute renal studies, including how the novel Global Kidney Patient Trials Network (GKPTN) could directly address protocol, recruitment and execution synergies.
The summit will also focus on five major themes of vital interest to industry members:
Maria serves as the Chief Medical Officer for George Clinical, responsible for continuing to build the organization’s enviable network of investigators and scientific leaders. Previously, she led the medical and safety services group at George Clinical who provide safety management, endpoint adjudication, medical monitoring and scientific leadership for both commercially sponsored and academic clinical trials. Maria has worked closely with the scientific leads at the George Institute to develop and implement scientific leadership models for George Clinical studies, as well as to develop new ideas for clinical research, and processes to improve clinical trial design and efficiencies. Maria has several years’ experience in both public health and clinical research as well as research management across a range of settings including hospitals, academic and clinical research organizations.
Professor Heerspink focuses on optimizing treatment strategies, finding new CKD therapeutic approaches and personalized medicine. He is Professor of Clinical Trials and Personalized Medicine and a clinical trialist at the Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen and Clinical Pharmacologist University Medical Center Groningen. His expertise includes clinical trial design and methodological aspects and statistical analyses of clinical trials.
Dr. Pecoits-Filho is a practicing Nephrologist and clinical investigator focused on evolving the way CKD patients are treated in day-to-day clinical practice by integrating observational research with clinical trials. He is the Scientific Director of the DOPPS program at Arbor Research Collaborative for Health, Michigan, and a professor of Medicine at the Pontifical Catholic University of Paraná, Brazil.
Boston, Massachusetts
Meet with George Clinical! Contact us to schedule a time now.
